7-727102-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017802.4(DNAAF5):c.382C>T(p.Pro128Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,084,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017802.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF5 | NM_017802.4 | c.382C>T | p.Pro128Ser | missense_variant | 1/13 | ENST00000297440.11 | NP_060272.3 | |
PRKAR1B | NM_001164760.2 | c.-23+108G>A | intron_variant | ENST00000537384.6 | NP_001158232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF5 | ENST00000297440.11 | c.382C>T | p.Pro128Ser | missense_variant | 1/13 | 1 | NM_017802.4 | ENSP00000297440.6 | ||
PRKAR1B | ENST00000537384.6 | c.-23+108G>A | intron_variant | 5 | NM_001164760.2 | ENSP00000440449.1 |
Frequencies
GnomAD3 genomes AF: 0.0000748 AC: 11AN: 147048Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000197 AC: 185AN: 937710Hom.: 0 Cov.: 30 AF XY: 0.000183 AC XY: 81AN XY: 442408
GnomAD4 genome AF: 0.0000748 AC: 11AN: 147048Hom.: 0 Cov.: 32 AF XY: 0.0000699 AC XY: 5AN XY: 71540
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2024 | The p.P128S variant (also known as c.382C>T), located in coding exon 1 of the DNAAF5 gene, results from a C to T substitution at nucleotide position 382. The proline at codon 128 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2021 | This sequence change replaces proline with serine at codon 128 of the DNAAF5 protein (p.Pro128Ser). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and serine. This variant has not been reported in the literature in individuals affected with DNAAF5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at